The Mechanisms by which Bax Induces the Apoptosis of Human Ovarian Cancer Cells
Abstract
The purpose of this study was to observe the apoptosis of A2780 cells transfected with the recombinant plasmid of pcDNA-Bax and to observe the release of cytochrome C from the mitochondria. Methods The recombinant plasmid of pcDNA-Bax was constructed and transfected into A2784 cells. The Hoechst 33258 stain method was applied to evaluate the apoptosis of the transfected cells and MTT mothod was used to test the cell viability. Western blot analysis was performed to determine the overexpression of Bax and the release of cytochrome C from the mitochondria. Results The recombinant plasmid of pcDNA-Bax was successfully constructed by using endonuclease digestion and the sequence analysis. The apoptosis of A2780 cells was induced after transfected with pcDNA3.1-Bax as demonstrated with Hoechst staining. The cell viability were decreased in the pcDNA3.1-Bax transfected group by MTT assay. The release of cytochrome C from the mitochondria was observed when using Western blotting analysis. And the caspase-9 and the caspase-3 were activated. Conclusion Our data suggestted that Bax exhibited potent pro-apoptotic activity against the ovarian cancer cells. This study is a foundation for the further research in the pro-apoptotic activity of Bax.
Keywords: Bax, Mitochondria, Eukaryotic expression, Apoptosis
Full Text:
PDFReferences
Meier P. Finch A, Evan G. Apoptosis in development. Nature,2000;407(6805):796-801.
Wei M, Zong W. Cheng E.etui. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 2001; 292( 5517): 727-730.
Parsons MJ. Green DR. Mitochondria in cell death. Essays Biochem.2010;47 :99-114. doi: 10. 1042/bse0470099.
Waterhouse N. Goldstein J. Von Ahsen O. et al. Cytochrome с maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol, 2001; 153 ( 2 ); 319- 328.
Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol.2000; 10(9) ;369-377.
Schuler M. Maurer U, Goldstein JC, et al. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ. 2003;10(4) :451-460.
Fraga H, Bech-Serra JJ, Canals F, et al. The mitochondrial intermembrane space oxireductase Mia40 funnels the oxidative folding pathway of the cytochrome с oxidase assembly protein Coxl9. J Biol Chem.2014 ;289(14 ) :9852-9864.
Jimenez-Gutierrez LR, Uribe-Carvajal S, Sanchez-Paz A, et al. The cytochrome с oxidase and its mitochondrial function in the whiteleg shrimp Litopenaeus vannamei during hypoxia. J Bioenerg Biomembr, 2014 ; 46(3); 189-196.
Widlak P, Garrard W. Roles of the major apoptotic nuclease- DNA fragmentation factor-in biology and disease. Cell Mol Life Sci.2009;66(2):263-274.
Milosevic J. Hoffarth S. Huber С, et al. The DNA damage- induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases. Oncogene, 2003; 22 ( 44 ) : 6852- 6856.
Jourdain A, Martinou JC. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int J Biochem Cell Biol,2009;41( 10); 1884-1889.
Blasius AL. Beutler В. Intracellular toll-like receptors. Immunity,2010;32(3) :305-315.
DelaRosa O, Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors; implications on therapeutic potential. Mediators Inflamm, 2010; 10 ( 2 ): 865- 601.
Zhang L. Liu D. Pu D, et al, The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells. Biol Res,2015;48( 1):6. doi: 10.1186/0717-6287-48-6.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell,2006; 124(4);783-801.
Pevsner-Fischer M, Morad V, Cohen-Sfady M, et al. Toll like receptors and their ligands control mesenchymal stem cell functions. Blood.2007; 109(4): 1422-1432.
Alaina BS, Chen BY, Marc LN, et al. Validation of the 2- calculation as alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diag Mol Path. 2006; 15 (1);56-61.
VanPoll D, Parekkadan В, Cho CH,et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology, 2008; 47 (5);1634-1643.
Kong D, Zhuang X. Wang D, et al. Umbilical cord mesenchymal stem cells transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin Lab. 2014; 60 (12):1969-1976.
Huang XP. Sun Z. Miyagi Y. et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation,2010; 122(23) :2419-2429.
Tomchuck SL, Zwezdaryk KJ, Coffel SB. et al. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells,2008; 26(1):99-107.
Refbacks
- There are currently no refbacks.



